<DOC>
	<DOC>NCT00439413</DOC>
	<brief_summary>The purpose of this study is designed to examine the effects of Selegiline Transdermal System and behavioral intervention in smoking cessation as compared to behavioral intervention alone.</brief_summary>
	<brief_title>Selegiline for Smoking Cessation - 1</brief_title>
	<detailed_description />
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Selegiline</mesh_term>
	<criteria>Must be at least 18 years of age Be in good general health Must meet Diagnostic and Statistical ManualIV (DSMIV) diagnostic criteria for nicotine dependence Be currently smoking &gt; 15 cigarettes/day, and have smoked cigarettes for the past 5 years Subjects must be motivated to quite smoking If female and of child bearing potential, agrees to use birth control and subject Subject must be able to understand and provide written informed consent. Exclusion Criteria: Please contact site for more information</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>